| Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion H Vogelsinger, S Weiler, A Djanani, J Kountchev, R Bellmann-Weiler, ... Journal of Antimicrobial chemotherapy 57 (6), 1153-1160, 2006 | 120 | 2006 |
| Liver allograft failure after nivolumab treatment—a case report with systematic literature research D Gassmann, S Weiler, JC Mertens, CS Reiner, B Vrugt, M Nägeli, ... Transplantation direct 4 (8), 2018 | 105 | 2018 |
| Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: an individual participant data analysis TH Collet, DC Bauer, AR Cappola, BO Åsvold, S Weiler, E Vittinghoff, ... The journal of clinical endocrinology & metabolism 99 (9), 3353-3362, 2014 | 98 | 2014 |
| Disease-specific sparing of the anterior semicircular canals in bilateral vestibulopathy AA Tarnutzer, CJ Bockisch, E Buffone, S Weiler, LM Bachmann, ... Clinical Neurophysiology 127 (8), 2791-2801, 2016 | 74 | 2016 |
| Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy S Weiler, C Seger, H Pfisterer, E Stienecke, F Stippler, R Welte, ... Antimicrobial agents and chemotherapy 57 (8), 4053-4057, 2013 | 67 | 2013 |
| Drug-induced liver injury: the dawn of biomarkers? S Weiler, M Merz, GA Kullak-Ublick F1000prime reports 7, 2015 | 65 | 2015 |
| Altered pharmacokinetics of voriconazole in a patient with liver cirrhosis S Weiler, H Zoller, I Graziadei, W Vogel, R Bellmann-Weiler, M Joannidis, ... Antimicrobial agents and chemotherapy 51 (9), 3459, 2007 | 56 | 2007 |
| Human tissue distribution of voriconazole S Weiler, D Fiegl, R MacFarland, E Stienecke, R Bellmann-Weiler, ... Antimicrobial agents and chemotherapy 55 (2), 925-928, 2011 | 55 | 2011 |
| Thromboembolic safety reporting of tofacitinib and baricitinib: an analysis of the WHO VigiBase E Vallejo-Yagüe, S Weiler, R Micheroli, AM Burden Drug Safety 43, 881-891, 2020 | 40 | 2020 |
| Clinical Course, Radiological Manifestations, and Outcome of Pneumocystis jirovecii Pneumonia in HIV Patients and Renal Transplant Recipients L Ebner, LN Walti, A Rauch, H Furrer, A Cusini, AMJ Meyer, S Weiler, ... PLoS One 11 (11), e0164320, 2016 | 37 | 2016 |
| Clinical manifestations, pathophysiology, treatment and outcome of inflammatory bowel diseases in older people M Butter, S Weiler, L Biedermann, M Scharl, G Rogler, HA Bischoff-Ferrari, ... Maturitas 110, 71-78, 2018 | 36 | 2018 |
| Teicoplanin pharmacokinetics in critically ill patients On Continuous veno-venous R Bellmann, G Falkensammer, C Seger, S Weiler, J Kountchev International journal of clinical pharmacology and therapeutics 48 (4), 243-249, 2010 | 29 | 2010 |
| Penetration of amphotericin B lipid formulations into pleural effusion S Weiler, R Bellmann-Weiler, M Joannidis, R Bellmann Antimicrobial agents and chemotherapy 51 (11), 4211-4213, 2007 | 29 | 2007 |
| Multimorbidity and quality of preventive care in Swiss university primary care cohorts S Streit, BR da Costa, DC Bauer, TH Collet, S Weiler, L Zimmerli, P Frey, ... PloS one 9 (4), e96142, 2014 | 27 | 2014 |
| Cardiovascular safety profile of romosozumab: a pharmacovigilance analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) A Vestergaard Kvist, J Faruque, E Vallejo-Yagüe, S Weiler, EM Winter, ... Journal of Clinical Medicine 10 (8), 1660, 2021 | 23 | 2021 |
| Pulmonary epithelial lining fluid concentrations after use of systemic amphotericin B lipid formulations S Weiler, G Falkensammer, A Hammerer-Lercher, M Anliker, ... Antimicrobial agents and chemotherapy 53 (11), 4934-4937, 2009 | 23 | 2009 |
| Levels of amphotericin B lipid formulations in ascites S Weiler, R Bellmann-Weiler, S Dunzendorfer, M Joannidis, R Bellmann Journal of antimicrobial chemotherapy 62 (5), 1163-1164, 2008 | 21 | 2008 |
| Incidence of differentiation syndrome associated with treatment regimens in acute myeloid leukemia: a systematic review of the literature L Gasparovic, S Weiler, L Higi, AM Burden Journal of clinical medicine 9 (10), 3342, 2020 | 17 | 2020 |
| Cetuximab induced aseptic meningitis A Ulrich, S Weiler, M Weller, T Rordorf, AA Tarnutzer Journal of Clinical Neuroscience 22 (6), 1061-1063, 2015 | 17 | 2015 |
| Radiation recall dermatitis induced by sorafenib: A case study and review of the literature S Stieb, O Riesterer, C Brüssow, BC Pestalozzi, M Guckenberger, ... Strahlentherapie und Onkologie 195 (5), 342-348, 2016 | 16 | 2016 |
Adrian Martinez-De la TorrePostdoc Econometrics for Pharmacoepidemiology, ETH Zurich | Cofounder, MethoddsPotvrđena adresa e-pošte na pharma.ethz.ch
